S&P 500   3,951.57
DOW   32,244.58
QQQ   305.97
5 Tech Stocks With Bank-Like Dividend Yields
The "King Of Quants" sees 10X potential... (Ad)
First Republic Bank Hits New Low, Dimon Pushes for More Cash
GBTC: The One Place to Buy Bitcoin for 58 Cents on the Dollar
The "King Of Quants" sees 10X potential... (Ad)
Mullen Automotive: Investment? No. Compelling Speculation, Yes 
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Free Stock Analysis Report: See The True Value of Any Stock (Ad)pixel
Which Gold Stocks Can Help You Hedge Bank Exposure?
General Mills Retreats To Buy Zone Ahead Of Earnings 
S&P 500   3,951.57
DOW   32,244.58
QQQ   305.97
5 Tech Stocks With Bank-Like Dividend Yields
The "King Of Quants" sees 10X potential... (Ad)
First Republic Bank Hits New Low, Dimon Pushes for More Cash
GBTC: The One Place to Buy Bitcoin for 58 Cents on the Dollar
The "King Of Quants" sees 10X potential... (Ad)
Mullen Automotive: Investment? No. Compelling Speculation, Yes 
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Free Stock Analysis Report: See The True Value of Any Stock (Ad)pixel
Which Gold Stocks Can Help You Hedge Bank Exposure?
General Mills Retreats To Buy Zone Ahead Of Earnings 
S&P 500   3,951.57
DOW   32,244.58
QQQ   305.97
5 Tech Stocks With Bank-Like Dividend Yields
The "King Of Quants" sees 10X potential... (Ad)
First Republic Bank Hits New Low, Dimon Pushes for More Cash
GBTC: The One Place to Buy Bitcoin for 58 Cents on the Dollar
The "King Of Quants" sees 10X potential... (Ad)
Mullen Automotive: Investment? No. Compelling Speculation, Yes 
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Free Stock Analysis Report: See The True Value of Any Stock (Ad)pixel
Which Gold Stocks Can Help You Hedge Bank Exposure?
General Mills Retreats To Buy Zone Ahead Of Earnings 
S&P 500   3,951.57
DOW   32,244.58
QQQ   305.97
5 Tech Stocks With Bank-Like Dividend Yields
The "King Of Quants" sees 10X potential... (Ad)
First Republic Bank Hits New Low, Dimon Pushes for More Cash
GBTC: The One Place to Buy Bitcoin for 58 Cents on the Dollar
The "King Of Quants" sees 10X potential... (Ad)
Mullen Automotive: Investment? No. Compelling Speculation, Yes 
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Free Stock Analysis Report: See The True Value of Any Stock (Ad)pixel
Which Gold Stocks Can Help You Hedge Bank Exposure?
General Mills Retreats To Buy Zone Ahead Of Earnings 
NASDAQ:LFCR

Lifecore Biomedical - LFCR Stock Forecast, Price & News

$3.10
+1.43 (+85.63%)
(As of 03/20/2023 12:00 AM ET)
Add
Compare
Today's Range
$1.80
$3.14
50-Day Range
$1.67
$7.26
52-Week Range
$1.52
$11.96
Volume
31.58 million shs
Average Volume
788,635 shs
Market Capitalization
$91.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.50

Lifecore Biomedical MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
206.5% Upside
$9.50 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.14mentions of Lifecore Biomedical in the last 14 days
Based on 19 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.29) to $0.05 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.81 out of 5 stars

Medical Sector

787th out of 988 stocks

Pharmaceutical Preparations Industry

378th out of 482 stocks


LFCR stock logo

About Lifecore Biomedical (NASDAQ:LFCR) Stock

Lifecore Biomedical, Inc. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. It operates through the following segments: Lifecore, Curation Foods, and Others. The Lifecore segment sells products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans. The Curation Foods segment includes activities to market and pack specialty packaged whole and fresh-cut fruit and vegetables. The Other segment consists of corporate general and administrative expenses, non-Curation Foods and non-Lifecore interest income, and income tax expenses. The company was founded by Ray Stewart on October 31, 1986 and is headquartered in Santa Maria, CA.

Receive LFCR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lifecore Biomedical and its competitors with MarketBeat's FREE daily newsletter.

LFCR Stock News Headlines

BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Q2 2023 Lifecore Biomedical Inc Earnings Call
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Critical Review: Lifecore Biomedical (LFCR) vs. Its Competitors
Should You Invest in Lifecore Biomedical (LFCR)?
LFCR Lifecore Biomedical, Inc.
Should You Hold Lifecore Biomedical (LFCR)?
See More Headlines
Receive LFCR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lifecore Biomedical and its competitors with MarketBeat's FREE daily newsletter.

LFCR Company Calendar

Today
3/20/2023
Next Earnings (Estimated)
4/04/2023
Fiscal Year End
5/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:LFCR
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$9.50
High Stock Price Forecast
$11.00
Low Stock Price Forecast
$8.00
Forecasted Upside/Downside
+206.5%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$-97,430,000.00
Pretax Margin
-20.04%

Debt

Sales & Book Value

Annual Sales
$185.79 million
Cash Flow
$6.60 per share
Book Value
$3.66 per share

Miscellaneous

Free Float
25,272,000
Market Cap
$91.76 million
Optionable
Optionable
Beta
1.11

Key Executives

  • James G. Hall
    President, Chief Executive Officer & Director
  • John D. Morberg
    CFO, Secretary & Chief Accounting Officer













LFCR Stock - Frequently Asked Questions

Should I buy or sell Lifecore Biomedical stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Lifecore Biomedical in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" LFCR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in LFCR, but not buy additional shares or sell existing shares.
View LFCR analyst ratings
or view top-rated stocks.

What is Lifecore Biomedical's stock price forecast for 2023?

1 Wall Street research analysts have issued 12 month price targets for Lifecore Biomedical's stock. Their LFCR share price forecasts range from $8.00 to $11.00. On average, they predict the company's share price to reach $9.50 in the next twelve months. This suggests a possible upside of 206.5% from the stock's current price.
View analysts price targets for LFCR
or view top-rated stocks among Wall Street analysts.

How have LFCR shares performed in 2023?

Lifecore Biomedical's stock was trading at $6.48 at the start of the year. Since then, LFCR stock has decreased by 52.2% and is now trading at $3.10.
View the best growth stocks for 2023 here
.

When is Lifecore Biomedical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 4th 2023.
View our LFCR earnings forecast
.

What is Lifecore Biomedical's stock symbol?

Lifecore Biomedical trades on the NASDAQ under the ticker symbol "LFCR."

How do I buy shares of Lifecore Biomedical?

Shares of LFCR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Lifecore Biomedical's stock price today?

One share of LFCR stock can currently be purchased for approximately $3.10.

How much money does Lifecore Biomedical make?

Lifecore Biomedical (NASDAQ:LFCR) has a market capitalization of $91.76 million and generates $185.79 million in revenue each year. The company earns $-97,430,000.00 in net income (profit) each year or ($2.50) on an earnings per share basis.

How can I contact Lifecore Biomedical?

Lifecore Biomedical's mailing address is 2811 AIRPARK DRIVE, SANTA MARIA CA, 93455. The official website for the company is www.lifecore.com. The company can be reached via phone at (800) 454-1355, via email at jeff.sonnek@icrinc.com, or via fax at 650-368-9818.

This page (NASDAQ:LFCR) was last updated on 3/21/2023 by MarketBeat.com Staff